氟替卡松呼气递送系统治疗慢性鼻窦炎的有效性:证据何在?
本文为综合文献综述,评估氟替卡松呼气递送系统(EDS-FLU)治疗慢性鼻窦炎的证据。近期大规模研究提示,其在伴鼻息肉和不伴鼻息肉的慢性鼻窦炎患者中均有效且安全:治疗后鼻窦结局测试评分降低20分,超过60%的患者息肉分级改善至少1分,伴鼻息肉患者使用EDS-FLU后手术指征约减少60%–70%。结论认为EDS-FLU是鼻腔鼻窦炎性疾病的重要辅助治疗。
要点
- EDS-FLU可将氟替卡松递送至鼻腔后部及中、上鼻道等较深区域。
- 治疗后鼻窦结局测试评分降低20分,超过60%患者息肉分级改善至少1分。
- 伴鼻息肉患者使用EDS-FLU后手术指征约减少60%–70%。
核心结论
- EDS-FLU是鼻腔鼻窦炎性疾病的重要辅助治疗。
研究设计与样本
- 综合文献综述。
主要发现
- 近期大规模研究提示EDS-FLU在伴鼻息肉和不伴鼻息肉的慢性鼻窦炎患者中均有效且安全。
- 研究显示治疗后鼻窦结局测试评分降低20分。
- 超过60%的患者息肉分级改善至少1分。
- 伴鼻息肉患者使用EDS-FLU后手术指征约减少60%–70%。
关键数值与推荐
- 治疗后鼻窦结局测试评分降低20分。
- 超过60%的患者息肉分级改善至少1分。
- 伴鼻息肉患者使用EDS-FLU后手术指征约减少60%–70%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intranasal steroids have become part of the mainstay in the long-term management of chronic rhinosinusitis. A long-standing problem remains in efficient and easy-to-use delivery of topical corticosteroids to the nasal mucosa. Currently available means of intranasal steroid delivery include sprays, which are generally limited to treating the anterior nasal cavity, and rinses, which are not FDA-approved for this indication. The exhalation delivery system is a novel method of delivering fluticasone to the deeper areas within the nasal cavities, including the posterior nasal cavity and middle and superior meatuses. METHODS: Comprehensive literature review. RESULTS: Recent large scale studies have suggested its efficacy and safety in the use of patients with both chronic sinusitis with polyposis and without polyps. Specifically, studies have demonstrated decreased Sinonasal Outcome Test scores of 20 points following treatment, as well as improvement of polyp grade by 1 or more point in more than 60% of patients. Furthermore, among patients with nasal polyps, there was approximately 60-70% decreased indication for surgery following EDS-FLU use. CONCLUSION: EDS-FLU is an important adjunct therapy for sinonasal inflammatory disease.
引用
- Kuan EC, Kovacs AJ, Workman AD, et al. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence? Int Forum Allergy Rhinol. 2019. PMID: 31087635. doi:10.1002/alr.22340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。